SubsidieMeestersTracking epigenetic plasticity in circulating tumor-derived DNA to monitor drug resistance and guide personalized treatment in cancer patients
EpiGuide aims to develop a blood-based assay to monitor epigenetic mechanisms of drug resistance in cancer, enhancing personalized treatment and early detection of therapy failure.
Projectdetails
Introduction
Personalized therapy has revolutionized cancer care during the past decades, but still suffers from frequent drug resistance and relapse. A better understanding of drug resistance mechanisms and their timely tracking and prevention represent areas of urgent clinical unmet need.
Drug Resistance Mechanisms
While novel or clonally selected genetic lesions, including DNA mutations and copy number changes, are well-known causes of therapy failure, emerging evidence supports a role for non-genetic/epigenetic heterogeneity and plasticity in the selective process to escape the pressure of therapy.
Need for Novel Tools
In addition to unraveling the mechanisms controlling this epigenetic plasticity to identify new therapeutic strategies, there is a growing need for novel tools to detect and monitor epigenetic heterogeneity and plasticity that currently do not exist.
EpiGuide Overview
EpiGuide aims to establish a blood-based monitoring tool to trace epigenetic mechanisms driving drug resistance development during treatment.
Development of EpiGuide Assay
I will develop and optimize the EpiGuide assay, an analytic and computational pipeline that measures and monitors methylation and histone modifications of circulating cell-free DNA that tumor cells shed into the blood plasma.
Validation of EpiGuide Assay
In a next step, the efficacy of the EpiGuide assay to detect epigenetic tumor cell state changes will be validated in mouse models and patient samples.
Exploration of Epigenetic Dynamics
The EpiGuide assay will also explore temporal and spatial dynamics of epigenetic switches related to drug resistance and look for associations with clinical outcomes.
Long-term Goals
The long-term goal is to bring the EpiGuide assay into clinical practice for monitoring in clinical trials and personalized cancer care.
Expected Impact
Major impact of EpiGuide is expected for guiding patient-tailored and disease state-adapted therapies, with a specific benefit of earlier detection of evolving non-genetic tumor cell states leading to drug resistance.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 1.998.625 |
| Totale projectbegroting | € 1.998.625 |
Tijdlijn
| Startdatum | 1-9-2022 |
| Einddatum | 31-8-2027 |
| Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- VIB VZWpenvoerder
- UNIVERSITEIT GENT
Land(en)
Vergelijkbare projecten binnen European Research Council
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
MANUNKIND: Determinants and Dynamics of Collaborative ExploitationThis project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery. | ERC STG | € 1.497.749 | 2022 | Details |
Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressureThe UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance. | ERC STG | € 1.498.280 | 2022 | Details |
Uncovering the mechanisms of action of an antiviral bacteriumThis project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function. | ERC STG | € 1.500.000 | 2023 | Details |
The Ethics of Loneliness and SociabilityThis project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field. | ERC STG | € 1.025.860 | 2023 | Details |
MANUNKIND: Determinants and Dynamics of Collaborative Exploitation
This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.
Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure
The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.
Uncovering the mechanisms of action of an antiviral bacterium
This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.
The Ethics of Loneliness and Sociability
This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Detecting epigenetic biomarkers in the blood for non-invasive precision oncologyDevelop new non-invasive diagnostic methods for cancer by analyzing epigenetic markers in circulating tumor DNA to improve sensitivity and monitor disease evolution. | ERC STG | € 1.500.000 | 2022 | Details |
Towards early cancer detection and tumor classification using epigenomic biomarkers in bloodEpiCblood aims to enhance early cancer detection by increasing cancer-specific cf-nucleosomes through innovative histone modification profiling and computational analysis for improved liquid biopsy assays. | ERC STG | € 1.499.999 | 2024 | Details |
Comprehensive Platform for the Functional Characterization of Cancer Epigenetics and DiagnosisEpiCancer aims to develop single-cell epigenetic analysis tools to understand cancer heterogeneity and improve diagnostics through blood tests, enhancing early detection and monitoring of tumors. | ERC STG | € 1.500.000 | 2024 | Details |
Exposing hidden targets of drug resistance in cancer by mapping the epitranscriptome at single-cell resolutionThis project aims to develop a method for single-cell m6A mapping in breast cancer to uncover novel drug resistance targets and improve therapeutic strategies against chemoresistance. | ERC STG | € 1.496.578 | 2024 | Details |
Detecting epigenetic biomarkers in the blood for non-invasive precision oncology
Develop new non-invasive diagnostic methods for cancer by analyzing epigenetic markers in circulating tumor DNA to improve sensitivity and monitor disease evolution.
Towards early cancer detection and tumor classification using epigenomic biomarkers in blood
EpiCblood aims to enhance early cancer detection by increasing cancer-specific cf-nucleosomes through innovative histone modification profiling and computational analysis for improved liquid biopsy assays.
Comprehensive Platform for the Functional Characterization of Cancer Epigenetics and Diagnosis
EpiCancer aims to develop single-cell epigenetic analysis tools to understand cancer heterogeneity and improve diagnostics through blood tests, enhancing early detection and monitoring of tumors.
Exposing hidden targets of drug resistance in cancer by mapping the epitranscriptome at single-cell resolution
This project aims to develop a method for single-cell m6A mapping in breast cancer to uncover novel drug resistance targets and improve therapeutic strategies against chemoresistance.